News

A new study by Kaiser Permanente has shown that the ABRYSVO respiratory syncytial virus vaccine is very effective in reducing emergency room visits and hospital stays due to RSV among older adults. “This Kaiser Permanente research demonstrated the real-world effectiveness of RSV vaccination among those 60 and over,” said lead author Sara Y. Tartof, PhD, MPH, ...

Exposure to a specific kind of air pollution, fine particulate matter, during pregnancy may significantly increase the risk of spontaneous preterm birth, which can be dangerous for both the mother and the baby, according to a Kaiser Permanente study published in JAMA Network Open. “Consistent with other study findings, this current study has demonstrated that there ...

Javed Sheikh, MD, was recently named 2024 Physician Researcher of the Year by the Southern California Permanente Medical Group. Dr. Sheikh is the vice area research chair for the Los Angeles area on the Regional Research Committee. He is chief of the Department of Allergy and Immunology at the Kaiser Permanente Los Angeles Medical Center and ...

After COVID-19 vaccines became available in December 2020, several smartphone-based reporting systems were developed to monitor vaccine side effects. They included V-safe from the Centers for Disease Control and Prevention. However, like most large surveillance systems, they had imperfections. Kaiser Permanente Southern California collaborated with the CDC and others to create a new system in April ...

Kristi Reynolds, PhD, MPH, is a chronic disease epidemiologist and the director of the Division of Epidemiologic Research for the Department of Research & Evaluation. Her research focuses on the prevention and treatment of hypertension, dyslipidemia, diabetes, and cardiovascular disease. She also studies medication adherence, drug safety, and cardiovascular quality of care and outcomes. Dr. Reynolds has more than ...

Research conducted at Kaiser Permanente has provided reassurance to the public and lawmakers by refuting claims that COVID-19 vaccines may increase the risk of cardiac-related death. “Our work reaffirms the previously established safety of COVID-19 vaccines,” said lead author Stanley Xu, PhD, of the Kaiser Permanente Southern California Department of Research & Evaluation. The study addressed concerns raised ...

A new Kaiser Permanente study explores factors that might influence whether people with new-onset heart failure get tested for coronary artery disease. Published November 1, 2024, in JACC: Advances, it suggests that physician perceptions of the risks and benefits of testing, patient preferences, and socioeconomic challenges may all come into play. The study follows research published ...

The updated national colorectal cancer screening guidelines that recommend screening begin at age 45 — rather than 50 — can benefit younger adults, a new Kaiser Permanente study found. The study was published October 22, 2024, in Annals of Internal Medicine. It included 267,732 Kaiser Permanente members in Northern California, Washington, and Colorado ages 45 to ...